Biosimilars

May 21, 2014 to May 22, 2014

Location Otto-Braun-Strasse 90, 10249
Berlin, Germany
Cost £3,687.81
Details Brand New for 2014:
Twice as much content - New 2-day conference on quality, CMC and analytical development of biosimilars

Unpublished data from Sandoz, Teva, Amgen, BIOCAD, Egis Pharmaceuticals and Livzon Mabpharm, Inc

Focused conference stream on clinical and non-clinical biosimilar development

Key reasons not to miss Biosimilars 2014:

Hospira and Egis Pharmaceuticals discuss the routes and launch strategy for the very first mAb biosimilar in Europe - how should you spend your resources?

Discover the latest on EU positions for interchangeability and substitution and comparison with the FDA proposals

Learn from Teva on how to carry out meaningful “fingerprint”-like analysis for effective biosimilar characterisation

Benchmark your global clinical biosimilar trials – experience from Sandoz examples with TNFa inhibitors.

Understand global development of biosimilars: with insight into Russia, CIS, Latin America and China

URLs:

Inquiries http://atnd.it/5736-2

Website http://atnd.it/5736-1

Price: £1,783.81 - £3,687.81
Venue Leonardo Royal Hotel Berlin Alexanderplatz
RSVP http://atnd.it/5736-0

add to calendar Add to Calendar
iCal | Outlook

 Return to Media Events